Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
This study has been completed.
Study NCT00314158   Information provided by Alcon Research
First Received: April 10, 2006   Last Updated: February 29, 2008   History of Changes

April 10, 2006
February 29, 2008
 
 
 
 
Complete list of historical versions of study NCT00314158 on ClinicalTrials.gov Archive Site
 
 
 
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
 

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

 
Phase III
Interventional
Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
  • Open-Angle Glaucoma
  • Ocular Hypertension
Drug: Brinzolamide 1%/Timolol 0.5%, Brinzolamide 1%, Timolol 0.5%
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
 
 
 

Inclusion Criteria:

  • Over 18 with open-angle glaucoma

Exclusion Criteria:

  • Under 18
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00314158
 
C-05-24
Alcon Research
 
 
Alcon Research
February 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP